Medicare Advisors Set To Meet On BMPs; AHRQ Tech Assessment Issued
This article was originally published in The Gray Sheet
Executive Summary
Evidence on the harms and benefits of bone morphogenetic protein orthopedic products will be scrutinized by Medicare advisors this week